One of the mechanisms by which HSP90 promotes CRC is stabilizing mutp53 via inhibition of Mdm2 and CHIP E3 ubiquitin ligases that usually degrade mutp53 [19]. Here, HSP90AB1 is linked to colorectal carcinoma.